European Journal of Oncology Nursing,
Journal Year:
2023,
Volume and Issue:
68, P. 102485 - 102485
Published: Dec. 9, 2023
Chemotherapy-induced
diarrhoea
(CID)
and
constipation
(CIC)
are
among
the
most
common
severe
gastrointestinal
symptoms
related
to
chemotherapy.
This
review
aimed
identify
describe
evidence
for
non-pharmacological
interventions
management
of
CID
CIC.
Frontiers in Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 5, 2024
The
imbalance
of
microbial
composition
and
diversity
in
favor
pathogenic
microorganisms
combined
with
a
loss
beneficial
gut
microbiota
taxa
results
from
factors
such
as
age,
diet,
antimicrobial
administration
for
different
infections,
other
underlying
medical
conditions,
etc.
Probiotics
are
known
their
capacity
to
improve
health
by
stimulating
the
indigenous
microbiota,
enhancing
host
immunity
resistance
infection,
helping
digestion,
carrying
out
various
functions.
Concurrently,
metabolites
produced
these
microorganisms,
termed
postbiotics,
which
include
compounds
like
bacteriocins,
lactic
acid,
hydrogen
peroxide,
contribute
inhibiting
wide
range
bacteria.
This
review
presents
an
update
on
using
probiotics
managing
treating
human
diseases,
including
complications
that
may
emerge
during
or
after
COVID-19
infection.
Complementary Therapies in Medicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 103151 - 103151
Published: Feb. 1, 2025
Fluoropyrimidines
and
irinotecan
cause
diarrhea,
which
can
be
particularly
severe
in
some
cases.
Probiotic
supplementation
is
a
potential
option
for
managing
chemotherapy-induced
diarrhea.
This
study
aims
to
evaluate
the
efficacy
safety
of
probiotics
diarrhea
induced
by
fluoropyrimidine
or
irinotecan-based
chemotherapy
cancer
patients.
A
literature
search
was
conducted
Cochrane
Library,
PubMed,
ScienceDirect,
SciFinder,
Scopus
August
2023.
Observational
prospective
studies
patients
receiving
5-fluorouracil,
capecitabine,
were
included.
RevMan
(version
5.4.1)
used
statistical
analysis.
The
protocol
registered
PROSPERO.
Of
9400
records,
24
14
included
systematic
review
meta-analysis,
respectively.
Most
provided
combination
probiotic
strains
from
initiation
completion
cycles.
significantly
reduced
all
grade
(RR
=
0.40;
95%
CI:
0.27,
0.60;
P
<
0.00001,
I2:
0%),
nausea
vomiting
0.49;
CI
[0.37,
0.67];
bloating
0.27;
[0.11,
0.69];
0.006,
0%)
anorexia
0.62:
[0.43,
0.90];
0.01,
39%)
compared
controls.
Absolute
risk
reductions
(ARR)
ranged
22.7%
28.5%,
with
number
needed
treat
(NNT)
value
3
5.
Moreover,
improved
intestinal
microbial
balance
symptom
scales
quality
life.
promising
manage
chemoradiotherapy-induced
without
serious
side
effects
fluoropyrimidines
regimens.
Given
clinically
meaningful
ARR
favorable
NNT
values,
may
have
role
clinical
practice.
However,
larger
trials
are
standardize
strain,
dosage,
duration,
target
patient
subgroups.
PROSPERO
database
(CRD42023473324).
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(21), P. 13268 - 13268
Published: Oct. 31, 2022
Oral
mucositis
is
a
common
adverse
effect
of
cancer
therapy.
Probiotics
have
been
shown
to
exert
anti-inflammatory
and
immunomodulatory
effects.
We
performed
meta-analysis
randomized
controlled
trials
(RCTs)
investigate
whether
probiotics
can
prevent
therapy–induced
oral
mucositis.
searched
PubMed,
Embase,
Cochrane
Library,
ClinicalTrials.gov
databases
for
related
published
before
September
2022;
no
language
restrictions
were
applied.
The
primary
outcome
was
the
incidence
severe
Secondary
outcomes
requirement
enteral
nutrition
during
treatment,
body
weight
loss,
decreased
quality
life.
study
has
registered
in
PROSPERO
(number:
CRD
42022302339).
Eight
RCTs,
including
708
patients,
reviewed;
however,
only
seven
could
be
performed.
Three
using
Lactobacilli-based
reported
that
probiotic
group
significantly
low
(risk
ratio
[RR]
=
0.84,
95%
confidence
interval
[CI]
0.77–0.93,
p
0.0004).
Seven
(RR
0.65,
CI
0.53–0.81,
<
0.0001).
(odds
0.34,
CI:
0.13–0.92,
0.05).
This
demonstrated
effectiveness
prevention
mitigation
recommend
use
treat
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: March 20, 2024
Abstract
The
oral
and
gastrointestinal
mucosae
represent
the
main
targets
of
toxic
effect
chemo
and/or
radiotherapy
administered
during
conditioning
regimen
before
hematopoietic
stem
cell
transplant
(HSCT).
These
harmful
consequences
immunological
complications
that
may
occur
after
(such
as
Graft
versus
Host
Disease,
G
v
HD)
are
responsible
for
clinical
symptoms
associated
with
mucositis
aplasia
phase,
like
pain,
nausea,
vomiting,
diarrhea.
toxicities
could
play
a
critical
role
in
microbiomes
post-transplant
degree
microbial
dysbiosis
dysregulation
among
different
bacterial
species
also
be
crucial
intestinal
mucosa
homeostasis,
altering
host’s
innate
adaptive
immune
responses
favoring
abnormal
occurrence
HD.
This
prospective
pediatric
study
aims
to
analyze
longitudinally
gut
17
patients
who
received
allogeneic
HSCT
malignant
non-malignant
diseases.
was
mainly
an
increased
relative
abundance
Fusobacteria
,
Prevotella
species,
while
Streptococcus
descendants
showed
negative
correlation.
fecal
microbiome
subjects
affected
by
cutaneous
acute
HD
(aG
correlated
Proteobacteria
.
Oral
mucosal
microbiota
undergoes
changes
HSCT,
Fusobacteria,
they
target
future
therapeutic
approaches,
revealed
increase
class
(
Alphaproteobacteria
Deltaproteobacteria
)
correlation
Gammaproteobacteria
BMC Oral Health,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: Jan. 3, 2023
Oral
mucositis
(OM)
is
a
major
side
effect
of
cancer
therapy,
which
associated
with
significant
symptoms,
treatment
delays
and
increased
costs
for
the
health
system.
It
an
important
component
quality
life
patients
and,
until
now,
there
has
been
no
gold
standard
regarding
prevention
or
this
pathology.
Notwithstanding
paucity
guidelines
(due
to
limited
evidence
from
high-quality,
rigorous
studies),
sodium
bicarbonate
(SB)
rinses
are
one
most
used
agents
OM
management.A
systematic
review
(2000-2022)
was
performed
in
order
compare
examine
different
versus
preventing
treating
OM.Eleven
randomized
controlled
trials
(RCT)
were
evaluated:
four
conducted
seven
management
OM.
The
risk
bias
RCTs
assessed
using
revised
Cochrane
tool
trials.According
RoB2
evaluation
trials,
judged
be
at
high
bias,
two
rated
as
'problematic',
while
five
deemed
low
bias.The
results
revealed
that
supporting
SB
prevention.Results
showed
takes
on
strategic
importance
use
prevention;
indiscriminate
could
counterproductive
because
it
causes
sudden
pH
increase
proper
pharmacological
treatment.
Journal of Multidisciplinary Healthcare,
Journal Year:
2024,
Volume and Issue:
Volume 17, P. 3497 - 3515
Published: July 1, 2024
Background:
Chemotherapy-induced
mucositis
is
inflammation
that
develops
in
the
oral
mucosal
due
to
anticancer
treatment.
Mucositis
has
negative
consequences
may
lead
distress
pediatric
patients,
resulting
escalated
expenses,
diminished
quality
of
life,
hindrance
cancer
therapy,
and
decreased
survival
rates.
However,
despite
numerous
methods,
care
protocols
are
suggested
for
implementation
population
a
lack
high-level
evidence
studies,
particularly
regarding
which
appropriate
agents
should
be
administered.
Purpose:
This
systematic
review
aimed
identify
effect
intervention
management
among
patients.
Methods:
Studies
were
published
between
2014
2023
from
five
databases:
PubMed,
Embase,
Medline,
ScienceDirect,
Scopus.
They
identified
using
search
strategy
relevant
studies
interventions
managing
children
with
cancer.
study
used
Joanna
Briggs
Institute
(JBI)
critical
appraisal
tools
assess
followed
recommended
reporting
items
reviews
meta-analyses
(PRISMA)
guidelines.
Results:
Eight
met
inclusion
criteria,
including
seven
RCTs
one
quasi-experimental
study.
Oral
involving
tooth
brushing,
mouthwash,
lip
performed
entirely
or
partially.
The
frequency
ranges
two
six
times
daily,
duration
5
days
weeks.
honey,
olive
oil,
Aloe
Vera,
Andiroba,
salivary
enzyme
toothpaste
beneficial
lower
severity
mucositis,
reduce
pain,
minimize
duration,
use
analgesics,
but
not
significantly
improve
child's
life.
Caphosol
mouthwash
did
mucositis.
Conclusion:
Our
highlights
effective
integratively,
vera,
toothpaste,
essential
manage
chemotherapy-induced
children.
Systematic
Review
Registration:
PROSPERO
registration
number
was
CRD42023456278.
Keywords:
children,
cancer,
chemotherapy,
care,
Pharmacia,
Journal Year:
2025,
Volume and Issue:
72, P. 1 - 9
Published: March 14, 2025
This
study
aimed
to
identify
the
effect
of
a
7-strain
probiotics
formulation
on
chemotherapy-related
side
effects,
complete
blood
counts,
biochemistry,
and
Karnofsky
performance
scores.
All
patients
diagnosed
with
breast
cancer
who
received
chemotherapy
at
hospital
in
Surabaya,
Indonesia,
were
considered
eligible
join
study.
Before
probiotic
supplementation,
baseline
values
tested
parameters
obtained
later
compared
after
21–30
days
supplementation.
Multi-strain
supplementation
could
alleviate
fatigue
nausea
symptoms
our
patients.
Significant
improvements
observed
before
scores
(median:
100
versus
90,
respectively;
p
<
0.001)
urea
nitrogen
(11.6
mg/dL
10.05
mg/dL,
=
0.008).
Non-significant
differences
found
for
alanine
aminotransferase,
serum
creatinine.
Our
findings
provide
preliminary
evidence
about
potential
role
multi-strain
effects.
BMC Oral Health,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: May 2, 2025
Oral
complications
following
cancer
treatment
are
a
challenging
issue
for
oncologists.
Several
studies
have
demonstrated
the
efficacy
of
biotics
in
prevention
and
oral
thyroid
head
neck
cancers.
Following
PRISMA
criteria,
systematic
review
meta-analysis
included
on
efficacy,
safety,
dosage,
duration
was
performed.
A
total
12
randomized
controlled
trials
885
individuals
were
this
meta-analysis.
Our
analysis
showed
that
had
slight
but
insignificant
effect
incidence
mucositis
(Risk
ratio
(RR)
=
0.90,
95%
CI
[0.79,
1.03]),
significant
impact
reducing
severity
(RR
0.62,
[0.48,
0.80]).
Biotics
also
developing
xerostomia
Head
(HNC)
patients.
Subgroup
Bifidobacterium-containing
products
more
effective
than
other
blends.
findings
safe
HNC
patients
suffering
from
complications.